Leukos Consultants Limited 14095687 false 2024-06-01 2025-05-31 2025-05-31 The principal activity of the company is that of consultancy activities. Digita Accounts Production Advanced 6.30.9574.0 true 14095687 2024-06-01 2025-05-31 14095687 2025-05-31 14095687 core:RetainedEarningsAccumulatedLosses 2025-05-31 14095687 core:ShareCapital 2025-05-31 14095687 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 14095687 bus:SmallEntities 2024-06-01 2025-05-31 14095687 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 14095687 bus:FullAccounts 2024-06-01 2025-05-31 14095687 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 14095687 bus:RegisteredOffice 2024-06-01 2025-05-31 14095687 bus:Director1 2024-06-01 2025-05-31 14095687 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 14095687 core:PlantMachinery 2024-06-01 2025-05-31 14095687 countries:AllCountries 2024-06-01 2025-05-31 14095687 2024-05-31 14095687 2023-06-01 2024-05-31 14095687 2024-05-31 14095687 core:RetainedEarningsAccumulatedLosses 2024-05-31 14095687 core:ShareCapital 2024-05-31 14095687 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 iso4217:GBP xbrli:pure

Registration number: 14095687

Leukos Consultants Limited
Annual Report and Unaudited Filleted Abridged Financial Statements
for the Year Ended 31 May 2025

Leukos Consultants Limited

Contents

Abridged Balance Sheet | 1 to 2
Notes to the Unaudited Abridged Financial Statements | 3 to 4

Leukos Consultants Limited

(Registration number: 14095687)
Abridged Balance Sheet as at 31 May 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 3,161 | 3,287
Current assets |  |  |
Debtors |  | 30,011 | 30,600
Cash at bank and in hand |  | 141,747 | 113,883
|  | 171,758 | 144,483
Creditors: Amounts falling due within one year |  | (48,308) | (35,332)
Net current assets |  | 123,450 | 109,151
Total assets less current liabilities |  | 126,611 | 112,438
Provisions for liabilities |  | (791) | (822)
Net assets |  | 125,820 | 111,616
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Profit and loss account |  | 125,720 | 111,516
Total equity |  | 125,820 | 111,616

Leukos Consultants Limited

(Registration number: 14095687)
Abridged Balance Sheet as at 31 May 2025

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

| The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
| The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the Company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 5 November 2025

Mr S Hilditch

Director

Leukos Consultants Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2025

1 | General information

The company is a private company limited by share capital, incorporated in United Kingdom (registered number 14095687).

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the director on 5 November 2025.

2 | Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when the amount of revenue can be reliably measured, it is probable the future economic benefits will flow into the entity, and specific criteria have been met for each of the company activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Leukos Consultants Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2025

Asset class | Depreciation method and rate
Plant and machinery | Reducing Balance 20%

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2024 - 3).

4 | Tangible assets

| Total £
Cost or valuation
At 1 June 2024 | 4,538
Additions | 665
At 31 May 2025 | 5,203
Depreciation
At 1 June 2024 | 1,251
Charge for the year | 791
At 31 May 2025 | 2,042
Carrying amount
At 31 May 2025 | 3,161
At 31 May 2024 | 3,287